Common Symptoms Leading to Testing
Sapropterin (tetrahydrobiopterin or BH4) deficiency often shows up in newborns with high blood phenylalanine levels from routine newborn screening for phenylketonuria (PKU). Infants may have poor feeding, vomiting, seizures, developmental delays, or unusual muscle tone. Hyperphenylalaninemia alone flags potential BH4 issues, as it disrupts phenylalanine hydroxylase.[1]
Step-by-Step Diagnostic Process
Diagnosis starts with elevated phenylalanine on newborn screening, prompting further tests:
1. Confirm phenylalanine levels: Repeat blood tests measure phenylalanine and tyrosine. Levels over 20 mg/dL suggest PKU or BH4 deficiency.
2. BH4 loading test: Patients get a single oral dose of sapropterin (20-30 mg/kg). Blood phenylalanine drops more than 30% within 24 hours in BH4-responsive cases, distinguishing it from classic PKU.[2][3]
3. Pterin analysis: Urine or cerebrospinal fluid tests for neopterin and biopterin ratios. Low biopterin or abnormal ratios confirm BH4 synthesis defects.
4. Dihydropteridine reductase (DHPR) assay: Blood enzyme test checks DHPR activity; low levels pinpoint specific BH4 recycling issues.
5. Genetic testing: Sequencing genes like GCH1, PTS, QDPR confirms mutations in over 60 known BH4 pathway genes.[4]
Full workup usually completes within days to weeks post-screening.
Why Newborn Screening Catches It Early
Most U.S. states include PKU screening, detecting 100% of cases by 24-48 hours of life. Untreated BH4 deficiency causes severe neurological damage faster than classic PKU, so rapid follow-up is critical.[5]
Challenges in Late or Atypical Diagnosis
Older children or adults may present with movement disorders (dystonia), psychiatric symptoms, or mild hyperphenylalaninemia missed at birth. Diagnosis then relies on clinical suspicion, BH4 challenge, and CSF analysis, which carries risks like headache or infection.[6]
Treatment Response as Confirmation
A sustained phenylalanine drop (over 4 weeks) on sapropterin therapy (Kuvan) verifies diagnosis and guides dosing, often combined with neurotransmitter precursors like levodopa.[7]
Sources
[1] NCBI Bookshelf: Tetrahydrobiopterin Deficiency
[2] European Journal of Human Genetics: BH4 Loading Test
[3] Molecular Genetics and Metabolism: Diagnostic Algorithm
[4] BH4.org: Genetic Confirmation
[5] GARD: Newborn Screening
[6] Journal of Pediatrics: Late Diagnosis
[7] FDA Kuvan Label